Rotations 2.0 Episode 6 Peripheral Arterial Disease

Episode 6 PAD

Shoot me any comments or questions @Rotation2ptoh  on X

Intro: Rock Christmas/ Christmas Music by tramp963

Outro: Waterfall by RomanSenykMusic

Courtesy of Pixabay for non-commericial educational use

Produced by: Todd Fredricks DO MSS

Edited by: Todd Fredricks DO MSS

Questions and Answers from Episodes 4 and 5

Week 4

Question 1: Prevalence of AF in HF

Which of the following statements is true regarding the prevalence of atrial fibrillation (AF) in heart failure (HF) patients?

 b) AF is diagnosed in approximately 44% of patients with acute HF.

Question 2: Catheter Ablation Recommendation

What is the current recommendation for catheter ablation in patients with atrial fibrillation and heart failure?

 c) Class 1 A recommendation for patients with HF with reduced ejection fraction (HFrEF) and end-stage HF.

Question 3: Effect of GDMT on AF

What is the effect of guideline-directed medical therapy (GDMT) for heart failure on the incidence of atrial fibrillations?

 c) Decreases the incidence of AF and progression of atrial myopathy.

Week 5

 Question 1

A 52-year-old male presents to your clinic for a routine health evaluation. He has no history of cardiovascular disease (CVD) but has a family history of premature atherosclerotic cardiovascular disease (ASCVD). His lipid panel reveals an LDL-C of 160 mg/dL, HDL-C of 45 mg/dL, and triglycerides of 180 mg/dL. Using the Pooled Cohort Equation (PCE), his 10-year ASCVD risk is calculated at 8%. According to the 2018 AHA/ACC cholesterol guidelines, which of the following is the most appropriate next step in managing his dyslipidemia?

 C. Evaluate risk-enhancing factors and discuss moderate-intensity statin therapy

Question 2

A 65-year-old female with a history of myocardial infarction 3 years ago is currently on atorvastatin 40 mg daily. Her recent lipid panel shows an LDL-C of 85 mg/dL. She reports no adverse effects from her medication. According to contemporary guidelines discussed in the article, which of the following is the most appropriate management strategy to further reduce her cardiovascular risk?

 C. Add ezetimibe to her regimen to achieve an LDL-C <55 mg/dL

Question 3

A 45-year-old male with type 2 diabetes and hypertension presents for follow-up. His lipid panel shows an LDL-C of 130 mg/dL and triglycerides of 220 mg/dL. He is not currently on lipid-lowering therapy. The article discusses the role of triglycerides in cardiovascular risk management. Based on this, which of the following statements best reflects the current guideline recommendations for managing his triglyceride levels?

 C. Consider triglyceride-lowering therapy if he is on a statin and has established ASCVD

Rotations  2.0 is copyrighted. But you can use any content from the podcast for non-commercial purposes under Creative Commons….BUT, BUT, BUT, you must cite Rotations 2.0 and Todd Fredricks DO MSS as the source of the material AND AND AND you cannot alter or edit the content in any manner without expressed permission of Todd Fredricks DO MSS.

Listeners interested in specifics from the paper authors should contact them directly through their respective institutions.

Any therapeutic ideas discussed should not be taken as any kind of medical advice or recommendations by the content creators. Listeners seeking advice about any medical care or decision-making should consult their own physician or medical provider and the content creators of Rotations 2.0 assume no liability for any listener's care or decision-making stemming from the topics discussed on Rotations 2.0.